| Orginal Article |
|
|
|
|
| Patent Analysis of Global Coronavirus Vaccine |
XIE Hua-ling,LV Lu-cheng,YANG Yan-ping( ) |
| National Science Library, Chinese Academy of Science, Beijing 100190, China |
|
|
|
Abstract Coronavirus is a kind of RNA virus which can infect human and animals. Coronavirus can cause severe diseases such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The coronavirus (SARS-CoV-2) is a new strain which has never been found in human body before. The rapid transmission of SARS-CoV-2 has aroused the attention of governments all over the world and actively sought for vaccines. This report based on the panoramic patent in the field of coronavirus vaccine, comprehensively analyzed the development trend of patents, the output of major countries and institutions. At the same time, the report focuses on revealing the development and distribution of human related vaccines, as well as the research and development status of human related vaccine products. The report aims to provide references and implications for scientific researchers and decision makers in the field of Coronavirus Vaccine.
|
|
Received: 09 February 2020
Published: 27 March 2020
|
|
|
|
Corresponding Authors:
Yan-ping YANG
E-mail: yangyp@mail.las.ac.cn
|
|
|
| [1] |
Gorbalenya A E, Enjuanes L, Ziebuhr J , et al. Nidovirales: evolving the largest RNA virus genome. Virus Res, 2006,117, 17-37.
|
|
|
| [2] |
ScienceDaily. Study: Pig virus is easily transmitted among chickens and turkeys.[2020-02-09]. https://www.sciencedaily.com/releases/2020/01/200115130430.htm.
|
|
|
| [3] |
CEPI. CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019.[2020-02-09]. https://cepi.net/news_cepi/cepi-to-fund-three-programmes-to-develop-vaccines-against-the-novel-coronavirus-ncov-2019/.
|
|
|
| [4] |
CNBC. Moderna working with the NIH on coronavirus vaccine.[2020-02-09]. https://www.cnbc.com/video/2020/01/27/moderna-working-with-the-nih-on-coronavirus-vaccine.html.
|
|
|
| [5] |
GSK. CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus. [2020-02-09]. https://www.gsk.com/en-gb/media/press-releases/cepi-and-gsk-announce-collaboration-to-strengthen-the-global-effort-to-develop-a-vaccine-for-the-2019-ncov-virus/.
|
|
|
| [6] |
Song Z, Xu Y, Bao L , et al. Pub crosstef From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 2019,11(1):E59.
|
|
|
| [7] |
Zhang N, Tang J, Lu L , et al. Receptorbinding domain-based subunit vaccines against MERS-CoV. Virus Res, 2015,202:151.
|
|
|
| [8] |
Schindewolf C, Menachery V . Middle East respiratory syndrome vaccine candidates: Cautious optimism. Viruses, 2019,11(1):E74.
|
|
|
| [9] |
Cho H, Excler J L, Kim J H , et al. Development of Middle East respiratory syndrome coronavirus vaccines - Advances and challenges. Hum Vaccin Immunother, 2018,14(2):304.
|
|
|
| [10] |
Li F, Du L Y . MERS coronavirus: An emerging zoonotic virus. Viruses, 2019,11(7):E663.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
